Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
256,606,920
-
Number of holders
-
727
-
Total 13F shares, excl. options
-
245,359,778
-
Shares change
-
+1,757,270
-
Total reported value, excl. options
-
$45,126,400,894
-
Value change
-
+$339,461,201
-
Put/Call ratio
-
85%
-
Number of buys
-
371
-
Number of sells
-
-276
-
Price
-
$183.95
Significant Holders of VERTEX PHARMACEUTICALS INC / MA - Common Stock (VRTX) as of Q1 2019
829 filings reported holding VRTX - VERTEX PHARMACEUTICALS INC / MA - Common Stock as of Q1 2019.
VERTEX PHARMACEUTICALS INC / MA - Common Stock (VRTX) has 727 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 245,359,778 shares
of 256,606,920 outstanding shares and own 96% of the company stock.
Largest 10 shareholders include PRICE T ROWE ASSOCIATES INC /MD/ (26,146,644 shares), FMR LLC (24,434,159 shares), BlackRock Inc. (20,176,298 shares), VANGUARD GROUP INC (19,481,561 shares), STATE STREET CORP (11,484,046 shares), Capital World Investors (10,913,727 shares), WELLINGTON MANAGEMENT GROUP LLP (8,828,785 shares), JENNISON ASSOCIATES LLC (6,800,436 shares), JPMORGAN CHASE & CO (6,783,635 shares), and Clearbridge Investments, LLC (5,314,705 shares).
This table shows the top 727 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.